E
bioAffinity Technologies, Inc. BIAF
$0.2872 -$0.0088-2.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -16.40% -13.89% -16.68% 11.46% -1.84%
Total Depreciation and Amortization 61.71% 142.53% 455.27% 886.58% 1,125.97%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 18.02% 32.17% 79.66% -71.67% -62.91%
Change in Net Operating Assets 492.74% -80.05% -145.03% 143.80% 218.65%
Cash from Operations 4.29% -20.32% -25.90% -18.11% -38.04%
Capital Expenditure -175.70% -243.91% 74.38% 77.95% 87.28%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 100.00% -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 96.01% 96.42% 97.31% -775.49% -779.35%
Total Debt Issued 492.42% -- -- -96.37% -96.56%
Total Debt Repaid -17.47% -4.67% 56.91% 60.88% 54.98%
Issuance of Common Stock 89.84% -- -- -81.36% -81.36%
Repurchase of Common Stock -- -- -247,350.00% -247,350.00% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 200.00% -- -- -100.00% -519.49%
Cash from Financing 164.08% 1,731.22% 526.92% -87.44% -87.41%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 72.55% 80.02% 58.25% -192.72% -183.70%